DiseaseID 5277

泰-萨克斯病

disease

NCI2016_02D:A rare, fatal, autosomal recessive lipid storage disorder caused by mutations in the HEXA gene. It is characterized by deficiency of beta-hexosaminidase A, resulting in accumulation of gangliosides in the neu

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Disease: 1Symptom: 4Target: 12Links: 16
Arranging relationship network...

Record Fields

Scalar fields from the final disease record.

Disease Id
5277
Core Entity Id
61751
Source Entity Count
1
Preferred Name
Tay-Sachs Disease
Name Cn
泰-萨克斯病
Name Pinyin
Tai - Sa Ke Si Bing
Name En
Tay-Sachs Disease
Name Latin
Bilingual Status
complete
Disease Type
disease
Umls Disease Type
Disease or Syndrome
Disgenet Type
disease
Mesh Class
Nervous System Diseases; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
Do Class
genetic disease; disease of metabolism
Hpo Class
Mesh Class Name
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
Hpo Class Name
Do Class Name
disease of metabolism; genetic disease
Disease Definition
NCI2016_02D:A rare, fatal, autosomal recessive lipid storage disorder caused by mutations in the HEXA gene. It is characterized by deficiency of beta-hexosaminidase A, resulting in accumulation of gangliosides in the neurons of the brain and spinal cord. Signs and symptoms include progressive deterioration of the mental and physical abilities early in life, accompanied by blindness, deafness, muscle atrophy, and paralysis.|MSH2017_2016_08_12:An autosomal recessive neurodegenerative disorder characterized by the onset in infancy of an exaggerated startle response, followed by paralysis, dementia, and blindness. It is caused by mutation in the alpha subunit of the HEXOSAMINIDASE A resulting in lipid-laden ganglion cells. It is also known as the B variant (with increased HEXOSAMINIDASE B but absence of hexosaminidase A) and is strongly associated with Ashkenazic Jewish ancestry.|MEDLINEPLUS_20151021:<p>Tay-Sachs disease is a rare, inherited disorder. It causes too much of a fatty substance to build up in the brain. This buildup destroys nerve cells, causing mental and physical problems.</p> <p>Infants with Tay-Sachs disease appear to develop normally for the first few months of life. Then mental and physical abilities decline. The child becomes blind, deaf, and unable to swallow. Muscles begin to waste away and paralysis sets in. Even with the best of care, children with Tay-Sachs disease usually die by age 4.</p> <p>The cause is a gene mutation which is most common in Eastern European Ashkenazi Jews. To get the disease, both parents must have the gene. If they do, there is a 25% chance of the child having the disease. A blood test and prenatal tests can check for the gene or the disease.</p> <p>There is no cure. Medicines and good nutrition can help some symptoms. Some children need feeding tubes.</p> <p >NIH: National Institute of Neurological Disorders and Stroke</p>|CSP2006:autosomal recessive inherited gangliosidosis characterized by the onset in the first 6 months of life of an exaggerated startle response, delay in psychomotor development, hypotonia (followed by spasticity), visual loss, and a macular cherry red spot; hexosaminidase A is deficient, leading to the accumulation of GM2 ganglioside in neurons of the central nervous system and retina; this condition is strongly associated with Ashkenazic Jewish ancestry.
Version
v1,v2
Suppressed
No

Names

Preferred names, aliases, and source labels retained in the final schema.

Name
Tay-Sachs Disease
Role
preferred
Name
Gm2-Gangliosidosis, Variant B1
Role
preferred
Name
Hexosaminidase A Deficiency, Adult Type
Role
preferred
Name
Hexosaminidase Alpha-Subunit Deficiency (Variant B)
Role
preferred
Name
Tay-Sachs Disease, Juvenile
Role
preferred
Name
Tay-Sachs Disease, Variant B1
Role
preferred
Name
Amaurotic Familial Idiocy
Role
preferred
Name
HEXA, CZECHOSLOVAKIAN ALLELE PHENOTYPE
Role
preferred
Name
Hexa, Czechoslovakian Allele
Role
alias

Cross References

Trusted external identifiers retained for this final record.

Herb
HBDIS002909HBDIS007244HBDIS016523HBDIS016524HBDIS016525HBDIS016527HBDIS019796HBDIS023458
Me Sh
D013661
Omim
272800
Umls
C0039373C1848913C1848914C1848915C1848916C1848917C1848922C2749283
Sym Map
SMDE00812SMDE09091SMDE09464SMDE09465SMDE13806SMDE13808
Do Class
DOID:0014667DOID:630
Dis Ge Net
C0039373C0282220C1848913C1848914C1848916C1848922C2749283C4017633
Umls Sty
T033T047
Me Sh Class
C10C16C18
Tcmbank Disease
179291949222025225432858230999321288657
Itcmdb Generated
ITX-DISEASE-D4B9BF394D7EITX-DISEASE-F063A158401A

Attributes

Merged source attributes and domain-specific metadata.

Version
v1,v2v2
Suppress
0
Do Class Name
disease of metabolism; genetic disease
Disease Type
diseasephenotype
Do Disease Class
genetic disease; disease of metabolism
Umls Disease Type
Disease or SyndromeFinding
Disease Definition
NCI2016_02D:A rare, fatal, autosomal recessive lipid storage disorder caused by mutations in the HEXA gene. It is characterized by deficiency of beta-hexosaminidase A, resulting in accumulation of gangliosides in the neurons of the brain and spinal cord. Signs and symptoms include progressive deterioration of the mental and physical abilities early in life, accompanied by blindness, deafness, muscle atrophy, and paralysis.|MSH2017_2016_08_12:An autosomal recessive neurodegenerative disorder characterized by the onset in infancy of an exaggerated startle response, followed by paralysis, dementia, and blindness. It is caused by mutation in the alpha subunit of the HEXOSAMINIDASE A resulting in lipid-laden ganglion cells. It is also known as the B variant (with increased HEXOSAMINIDASE B but absence of hexosaminidase A) and is strongly associated with Ashkenazic Jewish ancestry.|MEDLINEPLUS_20151021:<p>Tay-Sachs disease is a rare, inherited disorder. It causes too much of a fatty substance to build up in the brain. This buildup destroys nerve cells, causing mental and physical problems.</p> <p>Infants with Tay-Sachs disease appear to develop normally for the first few months of life. Then mental and physical abilities decline. The child becomes blind, deaf, and unable to swallow. Muscles begin to waste away and paralysis sets in. Even with the best of care, children with Tay-Sachs disease usually die by age 4.</p> <p>The cause is a gene mutation which is most common in Eastern European Ashkenazi Jews. To get the disease, both parents must have the gene. If they do, there is a 25% chance of the child having the disease. A blood test and prenatal tests can check for the gene or the disease.</p> <p>There is no cure. Medicines and good nutrition can help some symptoms. Some children need feeding tubes.</p> <p >NIH: National Institute of Neurological Disorders and Stroke</p>|CSP2006:autosomal recessive inherited gangliosidosis characterized by the onset in the first 6 months of life of an exaggerated startle response, delay in psychomotor development, hypotonia (followed by spasticity), visual loss, and a macular cherry red spot; hexosaminidase A is deficient, leading to the accumulation of GM2 ganglioside in neurons of the central nervous system and retina; this condition is strongly associated with Ashkenazic Jewish ancestry.
Me Sh Disease Class
Nervous System Diseases; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
Dis Ge Net Disease Type
diseasephenotype
Disease Class Name Me Sh
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
Umls Semantic Type Name
Disease or SyndromeFinding